The Centre for Cellular and Molecular Platforms (C-CAMP) has announced 12 winning technologies under the 2025–26 call of its Antimicrobial Resistance (AMR) in the Environment programme, supported by the UK Government's Global AMR Innovation Fund (GAMRIF) under the India AMR Innovation Hub (IAIH). 

The selected innovations are aimed at tackling antimicrobial resistance in environmental sources such as soil, water, and air, strengthening India's efforts to address one of the world's most pressing public health challenges.

Each winning technology will receive funding of up to £170,000 (approximately Rs. 2 crore), along with incubation support, access to technology platforms, mentorship, and networking opportunities to help translate research into commercially viable products. 

With the addition of the latest cohort, the India AMR Innovation Hub now supports a portfolio of 21 start-ups focused on environmental AMR solutions.

The India AMR Innovation Hub serves as the innovation arm of the Government of India's National Action Plan (NAP) 2.0 on AMR. It is anchored by C-CAMP and chaired by the Office of the Principal Scientific Adviser (OPSA) to the Government of India.

The newly selected innovations span the domains of detection, prevention, and treatment, addressing environmental pathways through which antimicrobial resistance develops and spreads.

Dr. Taslimarif Saiyed, Director-CEO, C-CAMP, said, "I am delighted to announce that the C-CAMP AMR in environment programme is adding 12 more exciting solutions to its portfolio through the C-CAMP GAMRIF partnership. These technologies will enable detection, prevention and treatment of soil, water, air and other sources to eliminate the risk of resistant pathogen build-up and leaching of antibiotics and other pharmaceuticals in the environment.”

Prof. Ajay K. Sood, Principal Scientific Adviser to the Government of India, said, "I congratulate the winners of the C-CAMP Programme for AMR in the Environment's 2025-26 call. Indian clinical research scientists have long stressed the need for the AMR fightback approach to be cross-sectoral and holistic and to go beyond drug discovery. C-CAMP has identified environmental causes and lack of contextual solutions for the environment to be the crucial missing pieces in our AMR response.